摘要
目的探讨CT定位下125I粒子植入治疗原发性肝癌TACE后残余病灶的临床应用价值。方法采用三维治疗计划系统(3D TPS)对23例肝细胞癌患者经导管动脉化疗栓塞术后37个残余病灶行CT引导下将125I粒子植入肿瘤内。结果 37个病灶完全缓解13个,部分缓解17个,无变化6个,进展1个。总有效率为81%。结论 CT引导下经皮穿刺植入125I粒子治疗肝细胞癌经导管化疗栓塞术后残余病灶创伤小,疗效肯定,并发症少,值得推广应用。
【Objective】 To assess the clinical value of CT guided 125I seeds implantation in hepatocellular carcinoma after transcatheter arterial chemoembolization.【Methods】 According to three dimensional therapy planning system（3D TPS）,125I seeds were implanted into 37 lesions of 23 patients with hepatocellular carcinoma after transcatheter arterial chemoembolization under CT guided approach.【Results】 Among all the lesions,13 lesions were completely remission（CR）,17 lesions were partial remission（PR）,6 lesions were no change and one lesion was deteriorated,the overall response（CR＋PR） rate was 81%.【Conclusion】 CT guided percutaneous implantation of 125I seeds should be a little invasive,effective and less complication method and should be widely applied in hepatocellular carcinoma after transcatheter arterial chemoembolization.
出处
《中国现代医学杂志》
CAS
CSCD
北大核心
2013年第4期71-74,共4页
China Journal of Modern Medicine
关键词
肝细胞癌
碘放射性核素
经导管动脉化学性栓塞术
hepatocellular carcinoma
iodineradioisotopes
transcatheter arterial chemoembolization
